Clinical trial

Effect of PDE5 Inhibition on Adipose Metabolism in Humans

NCT04684589

Study summary

ClinicalTrials.gov

Effect of PDE5 Inhibition on Adipose Metabolism in Humans

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Mapped RxNorm record Tadalafil 20 MG Normalized identity: tadalafil 20 MG View linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-03-16

PhasePHASE2

Conditions

Obesityverified · MONDO: obesity disorder

Interventions

Tadalafil 20 MGDRUG · verified · RxNorm: tadalafil 20 MG

PlaceboDRUG

Sponsors & collaborators

Vanderbilt University Medical Centerlead sponsor

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04684589 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.